Trials / Completed
CompletedNCT05089279
Study to Evaluate the Safety and Pharmacokinetics of CKD-349 in Healthy Adult Volunteers
An Open Label, Randomized, Single-dose, 2-sequence, 2-period, Cross-over Phase 1 Study to Evaluate the Safety and Pharmacokinetics of CKD-349 in Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 71 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
Study to Evaluate the Safety and Pharmacokinetics of CKD-349
Detailed description
An Open Label, Randomized, Single-dose, 2-sequence, 2-period, Cross-over Phase 1 Study to Evaluate the Safety and Pharmacokinetics of CKD-349 in Healthy Adult Volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | D113 | QD, PO |
| DRUG | CKD-349 | QD, PO |
Timeline
- Start date
- 2021-11-03
- Primary completion
- 2022-01-18
- Completion
- 2022-04-06
- First posted
- 2021-10-22
- Last updated
- 2022-10-07
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05089279. Inclusion in this directory is not an endorsement.